Indegene IPO: 10 key risks investors should know before subscribing to ₹1,842-crore issue
Also Read: Indegene IPO opens: GMP, subscription status, review, price, date, lot size, other details. Apply or not? There were sixty-five active clients of the business as of December 31, 2023.
With operating centres spanning Europe, Asia, and North America, the organisation provides them with solutions. They can deliver our solutions at scale around the globe because to their in-house created proprietary platforms based on machine learning (ML) and artificial intelligence (AI).
The ₹1,841.76 crore Indigene IPO consists of an offer-for-sale (OFS) of 23,932,732 equity shares by the investor selling shareholder, in addition to a fresh issuance of ₹760 crore. Also Read: Indegene IPO: Issue booked 1.30x on Day 1, so far.
NII, retail portion oversubscribed; check GMP, subscription status Here are some of the key risks listed by the company in its Red-Herring Prospectus (RHP): Also Read: Indegene IPO opens next week. GMP, review, price, other details of upcoming IPO in 10 points Also Read: Indegene IPO opens next week.
GMP, review, price, other details of upcoming IPO in 10 points Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decisions.Milestone Alert!
Livemint tops charts as the fastest growing news website in the world
